Effects of the valsartan recall on heart failure patients: A nationwide analysis
Joshua W. Devine,
Mina Tadrous,
Inmaculada Hernandez
et al.
Abstract:BackgroundValsartan is commonly used for cardiac conditions. In 2018, the Food and Drug Administration recalled generic valsartan due to the detection of impurities. Our objective was to determine if heart failure patients receiving valsartan at the recall date had a greater likelihood of unfavorable outcomes than patients using comparable antihypertensives.MethodsWe conducted a cohort study of Optum's de‐identified Clinformatics® Datamart (July 2017–January 2019). Heart failure patients with commercial or Med… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.